A detailed history of Black Rock Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 18,694,918 shares of CPRX stock, worth $404 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,694,918
Previous 17,732,642 5.43%
Holding current value
$404 Million
Previous $283 Million 2.45%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$14.68 - $16.92 $14.1 Million - $16.3 Million
962,276 Added 5.43%
18,694,918 $290 Million
Q1 2024

May 10, 2024

BUY
$13.18 - $17.11 $25.2 Million - $32.7 Million
1,910,343 Added 12.07%
17,732,642 $283 Million
Q4 2023

Feb 13, 2024

BUY
$11.78 - $17.29 $5.17 Million - $7.6 Million
439,279 Added 2.86%
15,822,299 $266 Million
Q3 2023

Nov 13, 2023

SELL
$11.69 - $15.02 $5.48 Million - $7.04 Million
-468,842 Reduced 2.96%
15,383,020 $180 Million
Q2 2023

Aug 11, 2023

BUY
$11.5 - $18.08 $5.65 Million - $8.89 Million
491,552 Added 3.2%
15,851,862 $213 Million
Q1 2023

May 12, 2023

SELL
$14.34 - $21.05 $4.73 Million - $6.95 Million
-330,016 Reduced 2.1%
15,360,310 $255 Million
Q4 2022

Feb 13, 2023

BUY
$12.25 - $19.5 $5.16 Million - $8.22 Million
421,395 Added 2.76%
15,690,326 $292 Million
Q3 2022

Nov 14, 2022

BUY
$7.06 - $15.52 $58.7 Million - $129 Million
8,317,115 Added 119.64%
15,268,931 $196 Million
Q2 2022

Aug 12, 2022

SELL
$6.23 - $8.57 $3.06 Million - $4.21 Million
-490,793 Reduced 6.59%
6,951,816 $48.7 Million
Q1 2022

May 12, 2022

SELL
$5.31 - $8.31 $1.29 Million - $2.01 Million
-242,089 Reduced 3.15%
7,442,609 $61.7 Million
Q4 2021

Feb 10, 2022

SELL
$5.21 - $7.45 $1.45 Million - $2.07 Million
-277,835 Reduced 3.49%
7,684,698 $52 Million
Q3 2021

Nov 09, 2021

SELL
$4.85 - $6.04 $210,024 - $261,556
-43,304 Reduced 0.54%
7,962,533 $42.2 Million
Q2 2021

Aug 11, 2021

BUY
$4.29 - $6.05 $34.3 Million - $48.4 Million
8,005,837 New
8,005,837 $46 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.